Machine learning for cancer therapies

Reverie Labs is a drug discovery company applying machine learning to develop cancer therapies. It engineers next-generation, brain-penetrant small molecules, using computational tools to design treatments for hard-to-reach tumors. Reverie Labs was acquired by Ginkgo Bioworks.